¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ (ÇÏÀ̺긮µå) Á¦40Â÷ KSTH Ãá°èÇмú´ëȸ : 2022-05-13

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ (ÇÏÀ̺긮µå) Á¦40Â÷ KSTH Ãá°èÇмú´ëȸ : 2022-05-13
±³À°ÀÏÀÚ : 2022-05-13
±³À°Àå¼Ò : ¼¼Á¾´ëÇб³ÄÁº¥¼Ç¼¾ÅÍ B1 ÄÁÆÛ·±½º·ë(¿Â-¿ÀÇÁ¶óÀÎ º´Çà)  
±³À°ÁÖÁ¦ : (ÇÏÀ̺긮µå) Á¦40Â÷ KSTH Ãá°èÇмú´ëȸ
ÁÖÃÖ±â°ü : Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ
´ã´çÀÚ : ±èÁø¾Æ
¿¬¶ôó : 02-790-2426  
À̸ÞÀÏ : ksth@thrombo.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаúÀÇ»çÇÐ, ¿¹¹æÀÇÇÐ, »ý¸®ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ÀÇ·á»çȸÇÐ, ÀÇ·áÀ±¸®ÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥, ÀÇ·á¹ý, ÀÇ·á°æ¿µ, ±âŸ
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 10,000¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ ¹× A·ë 09:00~09:30 Evaluate and treat the spectrum of TMA syndromes in pregnancy  ¾È¼­¿¬(Àü³²ÀÇ´ë Ç÷¾×Á¾¾ç³»°ú) 
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ ¹× A·ë 09:30~10:00 HIT : a diagnostic and therpeutic challenge  ¹Ú»óÇõ(¿ï»êÀÇ´ë Áø´Ü°Ë»çÀÇÇаú) 
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ ¹× A·ë 10:00~10:30 Interpretation of genetic testing for hereditary hemorrhagic, thrombotic, and platelet disorders  ±è³²Èñ(µ¿¾ÆÀÇ´ë Áø´Ü°Ë»çÀÇÇаú) 
È޽Ġ05-13  10:30~10:45 Coffee Break  () 
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ ¹× A·ë 10:45~11:15 Prevention and management of venous thromboembolism in pregnancy  È²Çå±Ô(¼øõÇâÀÇ´ë È£Èí±â³»°ú) 
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ ¹× A·ë 11:15~11:45 Medical consultations for thrombosis and hemostasis in real practice  ±è¾ç±â(¼øõÇâÀÇ´ë È£Èí±â³»°ú) 
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ ¹× A·ë 11:45~12:15 Update in cancer-associated thrombosis  ±è»ó¾Æ(ºÐ´ç¼­¿ï´ëº´¿ø Ç÷¾×Á¾¾ç³»°ú) 
½Ä»ç 05-13  12:15~13:15 Lunch  () 
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ ¹× A·ë 13:15~13:45 How to recognize and manage COVID-19-associated coagulopathy  ÀÌÁöÇö(µ¿¾ÆÀÇ´ë Ç÷¾×Á¾¾ç³»°ú) 
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ ¹× A·ë 13:45~14:15 COVID-19 and thrombosis  Á¶¿µÀç(ºÐ´ç¼­¿ï´ëº´¿ø È£Èí±â³»°ú) 
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ ¹× A·ë 14:15~14:45 COVID-19 vaccine and hematologic complications  ¹è¼ºÈ­(´ë±¸°¡Å縯ÀÇ´ë Ç÷¾×Á¾¾ç³»°ú) 
È޽Ġ05-13  14:45~15:00 Coffee Break  () 
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ ¹× A·ë 15:00~15:30 optimally utilize factor concentrates in hemophilia A  Çѽ¹Î(¿¬¼¼ÀÇ´ë ¼Ò¾Æ°ú) 
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ ¹× A·ë 15:30~16:00 Diagnostic and treatment challenges for acquired hemophilia A  Çö½Å¿µ(¿¬¼¼ÀÇ´ë Ç÷¾×³»°ú) 
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ ¹× A·ë 16:00~16:30 2021 Guidelines on the diagnosis/management of VWD  ÃÖ¿µ¹è(¾ÆÁÖÀÇ´ë ¼Ò¾Æ°ú) 
±âŸ 05-13 ¿Â¶óÀÎ ¹× A·ë 16:30~17:00 Çмú»ó ¹ßÇ¥ ¹× Æóȸ»ç  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ (ÇÏÀ̺긮µå) Á¦40Â÷ KSTH Ãá°èÇмú´ëȸ : 2022-05-13""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ)2022³â ´ëÇѺ´¸®ÇÐȸ º½Çмú´ëȸ(2ÀÏÂ÷) : 2022-05-13
´ÙÀ½±Û 2022³â ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2022-05-13
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
420 ¼­¿ï ´ëÇѺñ¸¸ÇÐȸ Á¦1ȸ ºñ¸¸Àü¹®°¡ ½ÉÈ­°úÁ¤: ºñ¸¸ Àü¹® ÀÎÁ¤ÀÇ ±³À° Part 1. : 2018-09-09 0 582 2018-08-15
419 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø 2018³â Çù·Âº´ÀÇ¿ø ÀÇ»ç ¿¬¼ö°­Á : 2018-09-09 0 1,364 2018-08-15
418 ¼­¿ï Á¦1ȸ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ESD¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-09-08 0 868 2018-08-15
417 ¼­¿ï Á¦11ȸ ¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø ÁßȯÀÚÀÇÇÐ ¿¬¼ö°­Á Basic Concepts in Intensive Care, 2018 (BACIC 2018) : 2018-09-08 0 1,382 2018-08-15
416 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ °í·Á´ëÇб³ °í°üÀý ½ÉÆ÷Áö¿ò : 2018-09-08 0 1,107 2018-08-15
415 ¼­¿ï 2018 ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ ¿öÅ©¼¥ : 2018-09-08 0 518 2018-08-15
414 ºÎ»ê ´ëÇѼ¼Æ÷º´¸®ÇÐȸ International Session of the 30th Annual Fall Meeting of the Korean Society for Cytopathology : 2018-09-08 0 599 2018-08-15
413 ºÎ»ê 2018³â ºÎ¿ï°æ³»ºÐºñ´ë»çÇÐȸ ´ç´¢º´±³À°ÀÚ ¼¼¹Ì³ª : 2018-09-08 0 1,043 2018-08-15
412 ±¤ÁÖ Àü³²´ëº´¿ø Á¦ 3Â÷ Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç ¿¬¼ö°­Á : 2018-09-08 0 1,091 2018-08-15
411 ºÎ»ê ºÎ»ê´ëº´¿ø 2018³â Á¦1Â÷ ¸ð¹ß¿¬¼ö±³À° (ÁÖÁ¦: Å»¸ðÁõÀÇ Áø´Ü°ú Ä¡·á) : 2018-09-08 0 1,434 2018-08-15
410 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¦6ȸ ¾ÆÁÖ ´ç´¢¹ß ¹× â»ó ½ÉÆ÷Áö¾ö : 2018-09-08 0 1,214 2018-08-15
409 ±¤ÁÖ 2018 Àü³²´ëÇб³º´¿ø ÁßȯÀÚÀÇÇнÉÆ÷Áö¿ò ¹× ±â°èȯ±â¿öÅ©¼ó : 2018-09-08 0 739 2018-08-15
408 ¼­¿ï 2018 ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ ¿öÅ©¼¥ : 2018-09-07 0 467 2018-08-15
407 ´ëÀü Ãæ³²´ëÇб³º´¿ø KMDS 2018³â °¡À»Áý´ãȸ : 2018-09-07 0 401 2018-08-15
406 °æ±â 2018³âµµ ¼º³²½Ã ¾È°úÀÇ»çȸ ½ÉÆ÷Áö¾ö : 2018-09-07 0 996 2018-08-15
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷